Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy
- PMID: 7658533
Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy
Abstract
Purpose: The usefulness of urinary beta-glucuronidase in screening and followup of urinary tract malignancy was tested.
Materials and methods: The activity and concentration of urinary beta-glucuronidase were determined in 80 healthy subjects, 113 urology patients with no cancer, and 60 with transitional cell and 23 with renal cell carcinoma. Patients with cancer were followed for 3 to 33 weeks.
Results: The enzyme activity and concentration were significantly greater in the cancer group, including residual tumor or recurrence after therapy, than in the controls with excellent discrimination.
Conclusions: Urinary beta-glucuronidase was indeed useful in screening and followup of urinary tract malignancy.
Comment in
-
"Wildcatting" for breakthroughs in urothelial cancer detection and management--a frustrating business.J Urol. 1995 Oct;154(4):1348-50. doi: 10.1016/s0022-5347(01)66858-7. J Urol. 1995. PMID: 7544837 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical